Abstract
Since its identification in 2001, awareness of fragile X-associated tremor/ataxia syndrome (FXTAS) and other fragile X-associated disorders (FXD) has increased. The number of patients and families impacted by these conditions continues to grow. Families with and without a known history of fragile X syndrome (FXS) are impacted, as the FXTAS diagnosis may be the first FXD diagnosed in the family. Patients are usually identified based on their neurological findings such as intentional tremor, balance and gait difficulties, cognitive impairment, and brain MRI abnormalities.
Don’t let a sense of desperation overtake you. You can have a good and happy life despite FXTAS. Care for your loved one, but don’t forget to take care of yourself as well. … look for and cultivate something good in each day. Keep connected to your family and friends and build a support system. Remember to keep your sense of humor.
—Marilyn Darwin, wife of Richard (deceased)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexopoulos GS, Raue P, Arean P (2003) Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatr Psychiatry 11(1):46–52
American Academy of Pediatrics, Committee on Bioethics, Genetics (2013) American College of Medical Genetics, Social, Ethical, and Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Pediatrics 131(3):620–622
Aziz M, Stathopulu E, Callias M, Taylor C, Turk J, Oostra B, Willemsen R, Patton M (2003) Clinical features of boys with fragile X premutations and intermediate alleles. Am J Med Genet 121B(1):119–127
Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ (2006) Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry 67(1):87–94
Basuta K, Schneider A, Gane L, Polussa J, Woodruff B, Pretto D, Hagerman R, Tassone F (2015) High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome. Am J Med Genet A 167A(9):2154–2161
Belmonte MK, Bourgeron T (2006) Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 9(10):1221–1225
Bombard Y, Penziner E, Suchowersky O, Guttman M, Paulsen JS, Bottorff JL, Hayden MR (2008) Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease. Eur J Hum Genet 16(3):279–289
Bourgeois JA, Farzin F, Brunberg JA, Tassone F, Hagerman P, Zhang L, Hessl D, Hagerman R (2006) Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci 18(2):171–177
Bourgeois JA, Coffey S, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ (2009) A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry 70(6):852–862
Cameron JI, Franche RL, Cheung AM, Stewart DE (2002) Lifestyle interference and emotional distress in family caregivers of advanced cancer patients. Cancer 94(2):521–527
Cameron JI, Cheung AM, Streiner DL, Coyte PC, Stewart DE (2006) Stroke survivors’ behavioral and psychologic symptoms are associated with informal caregivers’ experiences of depression. Arch Phys Med Rehabil 87(2):177–183
Castellvi-Bel S, Mila M, Soler A, Carrio A, Sanchez A, Villa M, Jimenez MD, Estivill X (1995) Prenatal diagnosis of fragile X syndrome: (CGG)n expansion and methylation of chorionic villus samples. Prenat Diagn 15(9):801–807
Clifford S, Dissanayake C, Bui QM, Huggins R, Taylor AK, Loesch DZ (2007) Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord 37(4):738–747
Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ (2008) Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 146A(8):1009–1016
Cornish KM, Sudhalter V, Turk J (2004) Attention and language in fragile X. Ment Retard Dev Disabil Res Rev 10(1):11–16
Cran DG, Johnson LA (1996) The predetermination of embryonic sex using flow cytometrically separated X and Y spermatozoa. Hum Reprod Update 2(4):355–363
Curlis Y, Zhang C, Holden JJ, Loesch PK, Mitchell RJ (2005) Haplotype study of intermediate-length alleles at the fragile X (FMR1) gene: ATL1, FMRb, and microsatellite haplotypes differ from those found in common-size FMR1 alleles. Hum Biol 77(1):137–151
De Jong A, De Wert G (2002) Screening for carriers of the fragile X syndrome; ethical exploration. Ned Tijdschr Geneeskd 146(13):611–615
Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R (2006) Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr 27(2 Suppl):S137–S144
Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, Mcconkie-Rosell A (2012) Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors. J Genet Couns 21(6):752–760
Gane LW, Flynn L, Hagerman RJ (2005) Needs and priorities of FXTAS patients and spouses determined using Q-sort methodology. In: The 12th International Workshop on Fragile X and X-Linked Mental Retardation, Williamsburg, VA, 26-29 August 2005
Gane LW, Iosif AM, Flynn-Wilson L, Venturino M, Hagerman RJ, Seritan AL (2010) Assessment of patient and caregiver needs in fragile X-associated tremor/ataxia syndrome by utilizing Q-sort methodology. Aging Ment Health 14(8):1000–1007
Geraedts JP, Harper J, Braude P, Sermon K, Veiga A, Gianaroli L, Agan N, Munne S, Gitlin S, Blenow E, De Boer K, Hussey N, Traeger-Synodinos J, Lee SH, Viville S, Krey L, Ray P, Emiliani S, Liu YH, Vermeulen S (2001) Preimplantation genetic diagnosis (PGD), a collaborative activity of clinical genetic departments and IVF centres. Prenat Diagn 21(12):1086–1092
Goodlin-Jones B, Tassone F, Gane LW, Hagerman RJ (2004) Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr 25(6):392–398
Grasso M, Faravelli F, Nigro CL, Chiurazzi P, Sperandeo MP, Argusti A, Pomponi MG, Lecora M, Sebastio GF, Perroni L, Andria G, Neri G, Bricarelli FD (1999) Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients. Am J Med Genet 85(3):311–316
Grigsby J, Brega AG, Jacquemont S, Loesch DZ, Leehey MA, Goodrich GK, Hagerman RJ, Epstein J, Wilson R, Cogswell JB, Jardini T, Tassone F, Hagerman PJ (2006) Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci 248(1-2):227–233
Grunfeld E, Coyle D, Whelan T, Clinch J, Reyno L, Earle CC, Willan A, Viola R, Coristine M, Janz T, Glossop R (2004) Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ 170(12):1795–1801
Hagerman RJ (2006) Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr 27(1):63–74
Hagerman PJ, Hagerman RJ (2004) The fragile-X premutation: a maturing perspective. Am J Hum Genet 74(5):805–816
Hagerman RJ, Hall DA, Coffey S, Leehey M, Bourgeois J, Gould J, Zhang L, Seritan A, Berry-Kravis E, Olichney J, Miller JW, Fong AL, Carpenter R, Bodine C, Gane LW, Rainin E, Hagerman H, Hagerman PJ (2008) Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging 3(2):251–262
Hall DA, Birch RC, Anheim M, Jonch AE, Pintado E, O’keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA (2014) Emerging topics in FXTAS. J Neurodev Disord 6(1):31
Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJ (2005) Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet 139(1):115–121
Hessl D, Glaser B, Dyer-Friedman J, Reiss AL (2006) Social behavior and cortisol reactivity in children with fragile X syndrome. J Child Psychol Psychiatry 47(6):602–610
Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ (2003) Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72(4):869–878
Jacquemont S, Farzin F, Hall D, Leehey M, Tassone F, Gane L, Zhang L, Grigsby J, Jardini T, Lewin F, Berry-Kravis E, Hagerman PJ, Hagerman RJ (2004a) Aging in individuals with the FMR1 mutation. Am J Ment Retard 109(2):154–164
Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ (2004b) Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291(4):460–469
Keysor CS, Mazzocco MM (2002) A developmental approach to understanding Fragile X syndrome in females. Microsc Res Tech 57(3):179–186
Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, Hagerman PJ (2007) Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord 22(2):203–206
Loesch DZ, Bui MQ, Hammersley E, Schneider A, Storey E, Stimpson P, Burgess T, Francis D, Slater H, Tassone F, Hagerman RJ, Hessl D (2015) Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clin Genet 87(2):173–178
Mcconkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, Sherman S, Nelson LM, Berry-Kravis E, Hessl D, Chiu S, Street N, Vatave A, Hagerman RJ (2007) Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. J Genet Couns 16(5):593–606
Mila M, Mallolas J (2001) [Fragile X syndrome: premature ovarian failure. Preimplantation and preconception genetic diagnosis]. Rev Neurol 33 Suppl 1:S20–S23
Nolin SL, Lewis FA 3rd, Ye LL, Houck GE Jr, Glicksman AE, Limprasert P, Li SY, Zhong N, Ashley AE, Feingold E, Sherman SL, Brown WT (1996) Familial transmission of the FMR1 CGG repeat. Am J Hum Genet 59(6):1252–1261
Nolin SL, Brown WT, Glicksman A, Houck GE, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E, Kooy F, Longshore J, Macpherson J, Mandel JL, Matthijs G, Rousseau F, Steinbach P, Vaisanen ML, Von Koskull H, Sherman S (2003) Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454–464
Nolin SL, Sah S, Glicksman A, Sherman SL, Allen E, Berry-Kravis E, Tassone F, Yrigollen C, Cronister A, Jodah M, Ersalesi N, Dobkin C, Brown WT, Shroff R, Latham GJ, Hadd AG (2013) Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A 161A(4):771–778
Nolin SL, Glicksman A, Ersalesi N, Dobkin C, Brown WT, Cao R, Blatt E, Sah S, Latham GJ, Hadd AG (2015) Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers. Genet Med 17(5):358–364
NSGC (2005) http://www.nsgc.org/consumer/definitions.cfm
Penagarikano O, Mulle JG, Warren ST (2007) The pathophysiology of fragile x syndrome. Annu Rev Genomics Hum Genet 8:109–129
Pozdnyakova I, Regan L (2005) New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level. FEBS J 272(3):872–878
Roberts JE, Chapman RS, Warren SF (2008) Speech and language development and intervention in down syndrome and fragile X syndrome. Paul H. Brookes, Baltimore
Ross, L. F., Saal, H. M., David, K. L., Anderson, R. R., American Academy of Pediatrics, American College of Medical Genetics and Genomics (2013) Technical report: ethical and policy issues in genetic testing and screening of children. Genet Med 15(3):234–245
Seritan AL, Nguyen DV, Farias ST, Hinton L, Grigsby J, Bourgeois JA, Hagerman RJ (2008) Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 147B(7):1138–1144
Sherman SL, Taylor K, Allen EG (2007) FMR1 premutation: a leading cause of inherited ovarian dysfunction. In: Arrieta I (ed) Fragile sites: new discoveries and changing perspectives. Nova Science, Hauppauge, pp 299–320
Tassone F (2015) Advanced technologies for the molecular diagnosis of fragile X syndrome. Expert Rev Mol Diag 15(11):1–9
Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66(1):6–15
Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, Li L, Hagerman RJ, Hagerman PJ (2007) CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet 144(4):566–569
Wheeler AC, Bailey DB Jr, Berry-Kravis E, Greenberg J, Losh M, Mailick M, Mila M, Olichney JM, Rodriguez-Revenga L, Sherman S, Smith L, Summers S, Yang JC, Hagerman R (2014) Associated features in females with an FMR1 premutation. J Neurodev Disord 6(1):30
Wingrove KJ, Norris J, Barton PL, Hagerman RJ (1996) Experiences and attitudes concerning genetic testing and insurance in a Colorado population: a survey of families diagnosed with fragile X syndrome. Am J Med Genet 64(2):378–381
Wirojanan J, Angkustsiri K, Tassone F, Gane LW, Hagerman RJ (2008) A girl with fragile X premutation from sperm donation. Am J Med Genet A 146A(7):888–892
Yrigollen CM, Martorell L, Durbin-Johnson B, Naudo M, Genoves J, Murgia A, Polli R, Zhou L, Barbouth D, Rupchock A, Finucane B, Latham GJ, Hadd A, Berry-Kravis E, Tassone F (2014) AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission. J Neurodev Disord 6(1):24
Acknowledgments
We would like to thank all the patients who have been diagnosed with FXTAS, FXD, and their many family members including those who have made contributions to this chapter. It is because of each of them that we continue to learn, change, and grow in our understanding of fragile X-associated disorders.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gane, L.W., Abrams, L. (2016). Genetic Counseling for FXTAS and Fragile X-Associated Disorders. In: Tassone, F., Hall, D. (eds) FXTAS, FXPOI, and Other Premutation Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-33898-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-33898-9_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33896-5
Online ISBN: 978-3-319-33898-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)